HeartWire 
(3/1, Hughes) reports, "Further details of bleeding events associated
with the introduction of dabigatran in New Zealand have highlighted the
problems of embracing a new drug too quickly."
(3/1, Hughes) reports, "Further details of bleeding events associated
with the introduction of dabigatran in New Zealand have highlighted the
problems of embracing a new drug too quickly."
MedPage Today
(3/1, Bankhead) reports, "A two-month review identified 78 bleeding
episodes, including a dozen major bleeds, one of which might have
contributed to a patient's death, the hematologists wrote in a letter
published in the March 1 issue of the New England Journal of
Medicine." A number "of the bleeding incidents involved older patients
and patients with impaired renal function." Meanwhile, "prescriber
error occurred in about a
fourth of the complications, suggesting a lack of awareness of the
potential risks associated with the drug."
(3/1, Bankhead) reports, "A two-month review identified 78 bleeding
episodes, including a dozen major bleeds, one of which might have
contributed to a patient's death, the hematologists wrote in a letter
published in the March 1 issue of the New England Journal of
Medicine." A number "of the bleeding incidents involved older patients
and patients with impaired renal function." Meanwhile, "prescriber
error occurred in about a
fourth of the complications, suggesting a lack of awareness of the
potential risks associated with the drug."
No comments:
Post a Comment